some positive signs emerging
FY23 sales order target of A$36M exceeded; Q3 FY23 sales orders of A$11.3M (TCV1) up 156% on A$4.4M in Q3 FY22, bringing year to date sales orders to A$37.1M
Contracted Annual Recurring Revenue (CARR) of A$20.6M; (A$20.0M at 31 Dec 2022)
Annual Recurring Revenue (ARR) run rate of A$17.2M; (A$16.4M at 31 Dec 2022)
Adventist Health System final sales orders received and deployment phase commenced
Cash on hand A$19.4M; (A$20.6M at 31 Dec 2022 )
Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-2
-
- There are more pages in this discussion • 30 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add M7T (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
59.0¢ |
Change
0.010(1.72%) |
Mkt cap ! $142.3M | |||
| Open | High | Low | Value | Volume |
| 58.0¢ | 60.0¢ | 57.5¢ | $66.82K | 112.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 25000 | 59.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 60.0¢ | 138015 | 1 |
View Market Depth
| Last trade - 15.36pm 24/07/2024 (20 minute delay) ? |
| M7T (ASX) Chart |